UPDATED Aug 22, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CGON | US$26.92 | 3.6% | -27.3% | US$2.0b | US$59.90 | PS3724.5x | E45.7% | n/a | ||
UTHR | US$312.23 | 0.5% | -10.3% | US$14.0b | US$380.57 | PE11.4x | E5.8% | n/a | ||
IMVT | US$15.24 | 2.7% | -53.0% | US$2.6b | US$39.46 | PB4.4x | E38.1% | n/a | ||
RXRX | US$4.94 | 3.3% | -36.7% | US$2.1b | US$6.47 | PS33.2x | E29.6% | n/a | ||
XNCR | US$8.41 | 13.0% | -52.4% | US$530.6m | US$25.20 | PS4.1x | E1.4% | n/a | ||
AXSM | US$118.51 | 1.2% | 34.7% | US$5.8b | US$176.95 | PS11.9x | E67.1% | n/a | ||
PHAT | US$11.91 | 8.8% | -13.9% | US$762.6m | US$21.38 | PS7.3x | E71.2% | n/a | ||
IBRX | US$2.31 | 3.1% | -45.6% | US$2.1b | US$10.20 | PS38.6x | E65.0% | n/a | ||
CPRX | US$21.08 | 2.5% | 3.7% | US$2.5b | US$34.29 | PE12.4x | E8.9% | n/a | ||
MRUS | US$67.49 | 1.3% | 25.9% | US$5.0b | US$90.40 | PS90.8x | E45.8% | n/a | ||
NAMS | US$25.00 | 2.3% | 53.8% | US$2.8b | US$40.27 | PS44x | E30.0% | n/a | ||
WVE | US$10.15 | 4.0% | 76.8% | US$1.6b | US$20.13 | PS17.2x | E24.4% | n/a | ||
PBH | US$66.71 | 1.9% | -7.0% | US$3.2b | US$82.80 | PE15.4x | E3.4% | n/a | ||
BEAM | US$16.64 | 3.9% | -37.9% | US$1.6b | US$45.92 | PS27.1x | E-1.3% | n/a | ||
CGTX | US$2.81 | 41.2% | 280.8% | US$146.2m | US$3.25 | PB29.4x | E-36.8% | n/a | ||
ELVN | US$20.85 | 5.1% | -9.3% | US$1.2b | US$41.25 | PB2.5x | E-19.1% | n/a | ||
GYRE | US$8.18 | 8.3% | -36.3% | US$685.7m | US$20.00 | PE178.4x | n/a | n/a | ||
ADPT | US$13.00 | 2.9% | 167.5% | US$1.9b | US$14.00 | PS9.6x | E42.5% | n/a | ||
NUVB | US$2.90 | 5.8% | 0.7% | US$937.8m | US$7.50 | PS69.1x | E36.3% | n/a | ||
IOVA | US$2.69 | 5.9% | -77.3% | US$919.1m | US$9.10 | PS4x | E59.3% | n/a | ||
FTRE | US$8.34 | 7.6% | -62.2% | US$703.2m | US$7.44 | PB1.3x | E57.3% | n/a | ||
ZYME | US$15.10 | 4.9% | 32.6% | US$1.1b | US$21.89 | PS9.2x | E-20.9% | n/a | ||
ORGO | US$4.89 | 9.4% | 66.9% | US$567.1m | US$8.00 | PS1.4x | E109.0% | n/a | ||
MNKD | US$4.11 | 4.3% | -23.5% | US$1.2b | US$9.25 | PE38.4x | E32.2% | n/a |